α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Open Access
- 15 July 1999
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 19 (14) , 5782-5791
- https://doi.org/10.1523/jneurosci.19-14-05782.1999
Abstract
α-Synuclein has been implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s disease. Mutations in α-synuclein cause some cases of familial PD (Polymeropoulos et al., 1997; Kruger et al., 1998). In addition, many neurodegenerative diseases show accumulation of α-synuclein in dystrophic neurites and in Lewy bodies (Spillantini et al., 1998). Here, we show that α-synuclein shares physical and functional homology with 14-3-3 proteins, which are a family of ubiquitous cytoplasmic chaperones. Regions of α-synuclein and 14-3-3 proteins share over 40% homology. In addition, α-synuclein binds to 14-3-3 proteins, as well as some proteins known to associate with 14-3-3, including protein kinase C, BAD, and extracellular regulated kinase, but not Raf-1. We also show that overexpression of α-synuclein inhibits protein kinase C activity. The association of α-synuclein with BAD and inhibition of protein kinase C suggests that increased expression of α-synuclein could be harmful. Consistent with this hypothesis, we observed that overexpression of wild-type α-synuclein is toxic, and overexpression of α-synuclein containing the A53T or A30P mutations exhibits even greater toxicity. The activity and binding profile of α-synuclein suggests that it might act as a protein chaperone and that accumulation of α-synuclein could contribute to cell death in neurodegenerative diseases.Keywords
This publication has 38 references indexed in Scilit:
- Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's diseaseFEBS Letters, 1998
- Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease MutationJournal of Biological Chemistry, 1998
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic MembranesJournal of Biological Chemistry, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteinsNeuroscience Letters, 1996
- NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively UnfoldedBiochemistry, 1996
- Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase CMolecular and Cellular Biochemistry, 1995
- Identification of two distinct synucleins from human brainFEBS Letters, 1994